Exercise Effect on Chemotherapy-Induced Neuropathic Pain

Running, not enrolling · Not applicable

Conditions studied: Cancer, Breast, Cancer, Colorectal, Cancer, Lung, Cancer, Ovarian

In brief

Chemotherapy-induced peripheral neuropathy (CIPN) continues to be a serious healthcare concern. It is painful, persistent, resistant to conventional pain therapies, and results in long-term suffering and decreased quality of life for many cancer survivors. The role of exercise to decrease CIPN-related neuropathic pain (CIPN-NP) will be investigated, with the goal of identifying the mechanisms associated with this therapeutic approach to manage CIPN-NP.

Key facts

Study ID
NCT02991677
Run by
Baltimore VA Medical Center
People needed
60
Starts
2018-03-01
Expected to finish
2025-12-01
Last updated by the study team
2024-08-06

Who can join

Age: 21 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.